FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
Comments Off on FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
June 4, 2026
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01 for Chronic Low Back Pain
Comments Off on FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01 for Chronic Low Back Pain
May 24, 2026
The FDA breakthrough therapy chronic low back pain designation for VER-01 marks a key regulatory milestone. This cannabis-derived treatment targets a widespread condition with high opioid reliance. VER-01's expedited development could offer a safer,…